Hughes VTE Student 2021 PDF

Document Details

2021

Gregory J. Hughes

Tags

venous thromboembolism medical treatment cardio-renal medicine

Summary

This document provides an overview of venous thromboembolism (VTE) management. It discusses drugs, diseases, cardio-renal aspects, objectives, content, additional readings, abbreviations, definitions and background. It is likely part of a course or study material.

Full Transcript

5 loner dose or 39 Hold warfin gud 59 continue Hold dose give K 540mg PO vitamk poss mg Serious IV vitamin K...

5 loner dose or 39 Hold warfin gud 59 continue Hold dose give K 540mg PO vitamk poss mg Serious IV vitamin K pulmonary artery neveervents platelets clottingfactors statis lower extremity sonogram Best exechocardiogram goldstandard goldstandard treated performance Mary pronylaxis choice parenteral oral Heparin concentrations low molecular weightheparin Tf nott cancer Directoral anticoagulants Directly blockingone of the a 2010 clotting factors who cats nave experience ofbloodcutting and arenigh ThotagY medically ill patients coagulationlabs askthepatient Ptpatient PTreferenceplasma warfarin monitoring LMWH Heparin corresponds amonogram heparin a single exapixaban or rivaroxaban magifferent with bridge differentage no bridge Doac amwH so spinal hematoma Both requirements heparinnomogram kidneys lateralabdomen 30 no routinemonitoring HAT on own withoutdoing anything continueheparinoverto immune 50 allergy secondary binds to za tnenaiezitgeqgnnou.rs hyper coagulable same Monger 25 46 10 20 3monthsorextended strongly vitaminK aipoonicio nonimmuneanaphylactic consistency anindicationforusinga differentdrugnowarfarin if patientcan'tadhereNeed diffoption after a e phosphOonpid glycoprotein never with after after Notforprophylaxis else is to prevent this is to treat pargetsageverything Treats clot dissolves got

Use Quizgecko on...
Browser
Browser